(Circulation. 2006;114:1645-1653.)
© 2006 American Heart Association, Inc.
Congenital Heart Disease for the Adult Cardiologist |
From University of Pennsylvania School of Medicine and Philadelphia Adult Congenital Heart Center, Hospital of the University of Pennsylvania, Childrens Hospital of Philadelphia (G.W.), Philadelphia, Pa, and the Adult Congenital Heart Center and Center for Pulmonary Arterial Hypertension, Royal Brompton Hospital and the National Heart and Lung Institute, Imperial College (M.A.G.), London, United Kingdom.
Correspondence to Gary Webb, MD, Professor of Medicine, University of Pennsylvania School of Medicine, 6 Penn Tower, 3400 Spruce St, Philadelphia, PA 19104-4283. E-mail gary.webb{at}uphs.upenn.edu
Key Words: heart defects, congenital heart septal defects remodeling surgery adult congenital heart disease tachyarrhythmias
| Introduction |
|---|
|
|
|---|
| Nomenclature and Classification |
|---|
|
|
|---|
|
| Prevalence |
|---|
|
|
|---|
| Genetic Factors |
|---|
|
|
|---|
| Sinus Venosus Atrial Septal Defects |
|---|
|
|
|---|
|
| Atrioventricular Septal Defects |
|---|
|
|
|---|
The most common associated anomalies are a secundum ASD and a persistent left SVC draining into the coronary sinus. Most primum ASDs are relatively large and lead to right heart dilation. Because of the trileaflet nature of the left AV valve (the so-called cleft mitral valve), variable degrees of valvular regurgitation are exceedingly common, whereas valvular stenosis is rare. A parachute type or double-orifice "mitral" valve may be present and may have prognostic implications. Depending on the severity of dysfunction of the left AV valve, patients with ostium primum ASDs may become symptomatic at a much younger age than patients with other types of ASDs. Surgical repair includes closure of the interatrial communication and restoration or preservation of left AV valve competence. In a series of 199 patients8 with a mean follow-up of 15.2 years, there were 7 late deaths, none of which were cardiac. Fifteen patients underwent reoperation for residual or recurrent left AV valve regurgitation, and 3 patients underwent reoperation for subaortic stenosis. Freedom from reoperation was 86%, and survival was 96% to 20 years. The occurrence of surgical complete heart block in these patients has practically disappeared in the modern era.9
| Pathophysiology |
|---|
|
|
|---|
| Clinical Features |
|---|
|
|
|---|
| Diagnostic Evaluation |
|---|
|
|
|---|
Electrocardiogram
The ECG may be an important clue to diagnosis (Figure 3).1215 The rhythm may be sinus, atrial fibrillation, or atrial flutter. Inverted P waves in the inferior leads suggest an absent or deficient sinus node, as may be seen in a sinus venosus defect.16,17 Right atrial overload is often present. First-degree heart block suggests a primum ASD18 but may be seen in older patients with a secundum ASD. The QRS axis is typically rightward in secundum ASD, markedly so if pulmonary hypertension is present. The QRS axis is leftward or extremely to the right in ostium primum ASDs. Voltage evidence of right ventricular hypertrophy may be seen in all ASDs, often in the form of "incomplete" right bundle-branch block, with the more extreme forms usually found in patients with pulmonary hypertension. Patients with mitral valve insufficiency may have left ventricular hypertrophy or left atrial overload.
|
Chest Radiograph
The chest x-ray film is often, but not always, abnormal in patients with significant ASDs.19,20 Cardiomegaly may be present from right heart dilation and occasionally from left heart dilation if significant mitral regurgitation is present in the patient with an ostium primum ASD. Right heart dilation is better appreciated in lateral films. The central pulmonary arteries are characteristically enlarged, with pulmonary plethora indicating increased pulmonary flow. A small aortic knuckle is characteristic, which reflects a chronically low systemic cardiac output state, because increased pulmonary flow in these patients occurs at the expense of reduced systemic flow.
Echocardiography
Transthoracic echocardiography documents the type(s) and size of the ASD(s), the direction(s) of the shunt, and, in experienced hands, the presence of anomalous pulmonary venous return. The functional importance of the defect can be estimated by the size of the right atrium and ventricle, the presence/absence of paradoxical septal motion (right ventricular volume overload), ventricular septal orientation in diastole (volume overload) and systole (pressure overload), and an estimation of the shunt ratio (based on pulmonary and aortic flows). Pulmonary artery systolic pressures may be estimated from the Doppler velocity of tricuspid regurgitation. In a patient with a primum ASD, the left AV valve is trileaflet (Figure 2B) and almost always demonstrates some regurgitation.
Transesophageal echocardiography may be useful to confirm the type of ASD and to delineate the pulmonary venous return. It is also commonly used in support of device closure of ASDs.
Cardiac Magnetic Resonance Imaging and Computed Tomographic Scanning
Cardiac MRI may be useful and may give the same type of information that echocardiography can provide. It is seen as providing the "gold standard" for the assessment of right ventricular size and function, and it may help define whether the right heart chambers are in fact enlarged (Figure 4). MRI is also excellent at assessing pulmonary venous return.21 In patients who cannot have an MRI, computed tomographic scanning and angiography can offer similar information.
|
Cardiac Catheterization
Cardiac catheterization is no longer a diagnostic necessity for many patients but has become increasingly important in delivering therapy to patients with secundum ASDs. A diagnostic catheter study may be required to evaluate pulmonary artery pressures, evaluate left heart function and hemodynamics, evaluate comorbid conditions, or assess the coronary arteries for the older patient.
| Management |
|---|
|
|
|---|
6 months after delivery.
|
Surgical closure is required for patients with ostium primum and sinus venosus ASDs, as well as for patients with secundum ASDs whose anatomy is unsuitable for device closure. In some settings, surgical closure of secundum defects is still preferred or required.23 A secundum ASD may be closed with direct sutures ("primary closure") or with a patch using pericardium or synthetic material. Ostium primum defects require patch closure and repair of the "cleft" AV valve. The repair of sinus venosus defects with anomalous pulmonary venous return can be technically challenging, and several approaches are used to achieve this.2427 Care must be taken to see that the lower end of the SVC is large enough to accommodate both the SVC and the pulmonary venous return being baffled to the left atrium. Alternatively, 2 separate channels may be created to ensure these 2 sources of venous return are unobstructed.
In most centers in the developed world, device closure has become the treatment of choice for secundum ASDs. The procedure is supported by transesophageal or intracardiac echocardiography.28 Catheter closure minimizes hospital stay and recovery, avoids surgical wounds and their potential complications, and conveys the same hemodynamic benefits as does surgery. Indications for catheter closure are the same as for surgical closure, but patient selection criteria are more narrowly defined. Patients with a stretched secundum ASD >36 mm, those with inadequate atrial septal rims to permit stable device deployment, or those with proximity of the defect to the AV valves, the coronary sinus, or the vena cavae are usually referred for surgical repair. Device closure is a safe and effective procedure in experienced hands, with major complications such as cardiac perforation or device embolization occurring in fewer than 1% of patients.2933 Successful closure is achieved in up to 95% of patients,34 although small residual shunts are often seen on echocardiography at the end of the procedure; these are not hemodynamically important, and most will close spontaneously within 1 year. Device closure of secundum ASDs can produce rapid and favorable cardiac remodeling, as described below. There is no consensus as to what constitutes appropriate follow-up of patients after ASD device closure. Although late complications appear rare, there is the potential for mitral valve dysfunction, obstruction to systemic and pulmonary venous pathways, and erosion or perforation of the atrial wall or aorta. Most physicians would follow up adult patients for at least 1 year, or longer if a particularly large device was deployed. After closure, a combination of low-dose aspirin and clopidogrel is usually prescribed for a minimum of 3 months.
| Pregnancy |
|---|
|
|
|---|
| Natural History and Long-Term Sequelae |
|---|
|
|
|---|
|
Two large studies have examined mortality and morbidity in surgically versus medically managed patients with ASDs over age 40 years, and neither showed a clear-cut survival benefit with the surgical strategy. The first retrospective study36 showed a survival benefit that favored the surgical patients, but this was after the exclusion of patients with coronary artery and mitral valve disease. The second study, a prospective, randomized trial conducted at the National Institute of Cardiology in Mexico City, Mexico,37 showed, perhaps surprisingly, no clear survival benefit to surgical closure. However, over the study period (of 15 years), surgery was superior to medical therapy for a composite clinical end point that included recurrent pneumonias, the latter being a major contributor toward the differences observed between the 2 subgroups. These 2 studies also highlight the challenge of conducting clinical trials in congenital heart disease, in which patient heterogeneity, even within the same diagnostic groups, and low mortality rates are often present. Furthermore, the low rates of clinical end points, such as death, reinforce the need for developing robust surrogate markers for monitoring congenital heart disease and its response to therapies.
Arrhythmia
Although atrial flutter and fibrillation are common and indeed anticipated in older patients with sizeable ASDs, sudden cardiac death is rare. Atrial tachyarrhythmia or bradyarrhythmia in these patients is the byproduct of longstanding right atrial dilation and stretch, which may be compounded by tricuspid regurgitation, pulmonary arterial hypertension, heart failure, and death.9,38 In the Mayo Clinic series, the prevalence of late atrial flutter or fibrillation rose progressively with mean age at surgery above 11 years,22 whereas in another series of ASD patients aged
60 years, arrhythmia prevalence was 52%.39 In our surgical series from Toronto, the preoperative and postoperative risks of atrial flutter or fibrillation were closely related to patient age above or below 40 years11 (Figure 6). In contrast, atrial flutter and fibrillation and sick sinus syndrome are very uncommon among patients who underwent ASD closure during childhood or early adulthood, even after long-term follow-up.40 Each of these long-term follow-up series highlighted the comorbidity of stroke in such patients. Older patients remain at risk of systemic thromboembolism despite complete closure of the ASD. The pulmonary veins are likely to be involved as a source of both arrhythmogenesis and thrombus formation. Although this is speculative, thromboprophylaxis should be considered for the older patient with an ASD for a period of 6 to 12 months after closure, while right heart and pulmonary venous remodeling takes place. Furthermore, such high-risk arrhythmia patients undergoing late ASD closure should be considered for a concomitant arrhythmia-targeting intervention. Kobayashi and colleagues41 demonstrated that in this setting, a surgical right atrial Maze procedure alone is usually ineffective in restoring and maintaining sinus rhythm after ASD closure, which supports the concept of left atrial and pulmonary venous involvement in arrhythmogenesis. Indeed, the same investigators showed that when a combined right and left modified Maze approach was used, success rates in restoring and maintaining sinus rhythm after ASD closure were much higher.
|
It is possible that device closure of ASDs may reduce the risk of atrial flutter and fibrillation if ASDs are closed at a younger age, if smaller defects are treated, and because of the absence of surgical scars, which themselves may act as a reentrant circuit for arrhythmia. Only early data are available on this point,42 however, and patients who undergo ASD closure late, whether surgical or catheter, have been subjected to the same chronic hemodynamic burden and thus have a similar arrhythmic potential.
Exercise Capacity
The functional capacity of patients with ASDs is substantially impaired.43 As in most forms of congenital heart disease, the patients subjective impression of physical capacity is much more optimistic than can be objectively demonstrated with peak oxygen uptake and other functional measures.44 Although patients often reported subjective improvement in their functional class after surgical closure of ASDs,36,45 it was only in 1997 that Helber and colleagues46 demonstrated a low peak oxygen uptake preoperatively, a slight increase 4 months after repair, and normal levels of performance and oxygen uptake 10 years after surgical ASD repair. Similar data have been reported more recently from device closure series.47 The favorable impact of ASD device closure on clinical performance appears both more widespread and faster than that reported in the surgical literature. Brochu and colleagues48 reported a 15% improvement in peak oxygen uptake at 6 months after device closure. This improvement was similar regardless of the size of the preprocedural left-to-right shunt (all patients in this series had sizeable ASDs) and regardless of patient age above or below 40 years (Figure 7). Giardini and colleagues4951 showed a similar clinical improvement, and they also documented improved left ventricular filling with concomitant improvement in systemic cardiac output in patients after device closure. The latter appears likely to be the main mechanism by which patients feel better and improve their exercise capacity after ASD closure. It follows that patients who undergo device closure have a much shorter recovery than those who require surgery and thus enjoy the benefits of improved hemodynamics and increased systemic cardiac output much earlier.
|
Cardiac Remodeling
Cardiac remodeling occurs quite quickly after ASD device closure.47,5255 Reduced right atrial and ventricular volumes are apparent within 24 hours, and probably earlier. The remodeling process appears to continue for at least 1 year (Figure 4) and is more advanced in the right ventricle than the right atrium.42 Furthermore, the magnitude of right atrial remodeling is inversely related to patient age at the time of closure, as demonstrated in another study that reported persistent right atrial dilation in up to 64% of patients who underwent late ASD closure, which in turn was associated with elevation of brain natriuretic peptide levels and right ventricular diastolic dysfunction.56 All these data clearly argue for early and timely closure of ASDs at the time of diagnosis.
Pulmonary Arterial Hypertension
Pulmonary arterial hypertension occurs to a mild-to-moderate degree in many patients as a reflection of aging and altitude of residence.5760 Pulmonary vascular disease may occur in up to 5% to 10% of patients with untreated ASDs, predominantly in females.61 The pathogenesis of the pulmonary arterial hypertension in such patients is unknown, but it does not appear to be caused solely by the magnitude of the shunt persisting for decades. As a rule, patients should be considered to have Eisenmenger syndrome when ASDs are large and unrestrictive and when there is resting cyanosis. If a smaller ASD is present in a patient with pulmonary hypertension, other causes should be sought. There are some ASD patients in whom repair is not possible because of high pulmonary arterial pressures and pulmonary vascular resistance, usually when the left-to-right shunt is reversed. There have been case reports of such patients being managed with intravenous epoprostenol or oral bosentan with such success that ASD closure subsequently became possible.62,63
| Conclusions |
|---|
|
|
|---|
| Acknowledgments |
|---|
Disclosures
None.
| References |
|---|
|
|
|---|
2. Uebing A, Steer PJ, Yentis SM, Gatzoulis MA. Pregnancy and congenital heart disease. BMJ. 2006; 332: 401406.
3. Basson CT, Huang T, Lin RC, Bachinsky DR, Weremowicz S, Vaglio A, Bruzzone R, Quadrelli R, Lerone M, Romeo G, Silengo M, Pereira A, Krieger J, Mesquita SF, Kamisago M, Morton CC, Pierpont ME, Muller CW, Seidman JG, Seidman CE. Different TBX5 interactions in heart and limb defined by Holt-Oram syndrome mutations. Proc Natl Acad Sci U S A. 1999; 96: 29192924.
4. Schott JJ, Benson DW, Basson CT, Pease W, Silberbach GM, Moak JP, Maron BJ, Seidman CE, Seidman JG. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998; 281: 108111.
5. Srivastava D, Olson EN. A genetic blueprint for cardiac development. Nature. 2000; 407: 221226.[CrossRef][Medline] [Order article via Infotrieve]
6. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC, Srivastava D. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003; 424: 443447.[CrossRef][Medline] [Order article via Infotrieve]
7. Taylor NC, Somerville J. Fixed subaortic stenosis after repair of ostium primum defects. Br Heart J. 1981; 45: 689697.
8. King RM, Puga FJ, Danielson GK, Schaff HV, Julsrud PR, Feldt RH. Prognostic factors and surgical treatment of partial atrioventricular canal. Circulation. 1986; 74 (pt 2): I-42I-46.[Medline] [Order article via Infotrieve]
9. Gatzoulis MA, Hechter S, Webb GD, Williams WG. Surgery for partial atrioventricular septal defect in the adult. Ann Thorac Surg. 1999; 67: 504510.
10. Therrien J, Warnes C, Daliento L, Hess J, Hoffmann A, Marelli A, Thilen U, Presbitero P, Perloff J, Somerville J, Webb GD. Canadian Cardiovascular Society Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease part III. Can J Cardiol. 2001; 17: 11351158.[Medline] [Order article via Infotrieve]
11. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999; 340: 839846.
12. Nadrai A. ECG in the diagnostics of atrial septal defect. Acta Paediatr Acad Sci Hung. 1964; 65: 201215.
13. Heller J, Hagege AA, Besse B, Desnos M, Marie FN, Guerot C. "Crochetage" (notch) on R wave in inferior limb leads: a new independent electrocardiographic sign of atrial septal defect. J Am Coll Cardiol. 1996; 27: 877882.[Abstract]
14. Zufelt K, Rosenberg HC, Li MD, Joubert GI. The electrocardiogram and the secundum atrial septal defect: a reexamination in the era of echocardiography. Can J Cardiol. 1998; 14: 227232.[Medline] [Order article via Infotrieve]
15. Guray U, Guray Y, Yylmaz MB, Mecit B, Sasmaz H, Korknaz S, Kutuk E. Evaluation of P wave duration and P wave dispersion in adult patients with secundum atrial septal defect during normal sinus rhythm. Int J Cardiol. 2003; 91: 7579.[CrossRef][Medline] [Order article via Infotrieve]
16. Jost CH, Connolly HM, Danielson GK, Bailey KR, Schaff HV, Shen WK, Warnes CA, Seward JB, Puga FJ, Tajik AJ. Sinus venosus atrial septal defect: long-term postoperative outcome for 115 patients. Circulation. 2005; 112: 19531958.
17. Davia JE, Cheitlin MD, Bedynek JL. Sinus venosus atrial septal defect: analysis of fifty cases. Am Heart J. 1973; 85: 177185.[CrossRef][Medline] [Order article via Infotrieve]
18. Fournier A, Young ML, Garcia OL, Tamer DF, Wolff GS. Electrophysiologic cardiac function before and after surgery in children with atrioventricular canal. Am J Cardiol. 1986; 57: 11371141.[CrossRef][Medline] [Order article via Infotrieve]
19. Egeblad H, Berning J, Efsen F, Wennevold A. Non-invasive diagnosis in clinically suspected atrial septal defect of secundum or sinus venosus type: value of combining chest x-ray, phonocardiography, and M-mode echocardiography. Br Heart J. 1980; 44: 317321.
20. Reading M. Chest x-ray quiz: an atrial septal defect. Aust Crit Care. 2000; 13: 96119.[Medline] [Order article via Infotrieve]
21. Prasad SK, Soukias N, Hornung T, Khan M, Pennell DJ, Gatzoulis MA, Mohiaddin RH. Role of magnetic resonance angiography in the diagnosis of major aortopulmonary collateral arteries and partial anomalous pulmonary venous drainage. Circulation. 2004; 109: 207214.
22. Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, McGoon DC, Puga FJ, Kirklin JW, Danielson GK. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years. N Engl J Med. 1990; 323: 16451650.[Abstract]
23. Vida VL, Barnoya J, OConnell M, Leon-Wyss J, Larrazabal LA, Castaneda AR. Surgical versus percutaneous occlusion of ostium secundum atrial septal defects: results and cost-effective considerations in a low-income country. J Am Coll Cardiol. 2006; 47: 326331.
24. Shahriari A, Rodefeld MD, Turrentine MW, Brown JW. Caval division technique for sinus venosus atrial septal defect with partial anomalous pulmonary venous connection. Ann Thorac Surg. 2006; 81: 224229.
25. Baskett RJ, Ross DB. Superior vena cava approach to repair of sinus venosus atrial septal defect. J Thorac Cardiovasc Surg. 2000; 119: 178180.
26. Lee KS, Chen YF, Chiu CC, Lin YT, Lee CS, Lai WT. Surgical correction of sinus venosus atrial septal defect associated with partial anomalous pulmonary venous connection to high superior vena cava: case report. Gaoxiong Yi Xue Ke Xue Za Zhi. 1994; 10: 592596.[Medline] [Order article via Infotrieve]
27. Hamilton JR, Brooks SG, Walker DR. Alternative technique for repair of sinus venosus atrial septal defect. Ann Thorac Surg. 1991; 51: 144146.[Abstract]
28. Mullen MJ, Dias BF, Walker F, Siu SC, Benson LN, McLaughlin PR. Intracardiac echocardiography guided device closure of atrial septal defects. J Am Coll Cardiol. 2003; 41: 285292.
29. Costache V, Chavanon O, Thony F, Blin D. Aortic arch embolization of an Amplatzer occluder after an atrial septal defect closure: hybrid operative approach without circulatory arrest. Eur J Cardiothorac Surg. 2005; 28: 340342.
30. Knirsch W, Dodge-Khatami A, Balmer C, Peuster M, Kadner A, Weiss M, Pretre R, Berger F. Aortic sinus-left atrial fistula after interventional closure of atrial septal defect. Catheter Cardiovasc Interv. 2005; 66: 1013.[CrossRef][Medline] [Order article via Infotrieve]
31. Ruge H, Wildhirt SM, Libera P, Vogt M, Holper K, Lange R. Images in cardiovascular medicine: left atrial thrombus on atrial septal defect closure device as a source of cerebral emboli 3 years after implantation. Circulation. 2005; 112: e130e131.
32. Saxena A, Divekar A, Soni NR. Natural history of secundum atrial septal defect revisited in the era of transcatheter closure. Indian Heart J. 2005; 57: 3538.[Medline] [Order article via Infotrieve]
33. Mashman WE, King SB, Jacobs WC, Ballard WL. Two cases of late embolization of Amplatzer septal occluder devices to the pulmonary artery following closure of secundum atrial septal defects. Catheter Cardiovasc Interv. 2005; 65: 588592.[CrossRef][Medline] [Order article via Infotrieve]
34. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol. 2002; 39: 18361844.
35. Campbell M. Natural history of atrial septal defect. Br Heart J. 1970; 32: 820826.
36. Konstantinides S, Geibel A, Olschewski M, Gornandt L, Roskamm H, Spillner G, Just H, Kasper W. A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med. 1995; 333: 469473.
37. Attie F, Rosas M, Granados N, Zabal C, Buendia A, Calderon J. Surgical treatment for secundum atrial septal defects in patients >40 years old: a randomized clinical trial. J Am Coll Cardiol. 2001; 38: 20352042.
38. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002; 106: 9299.
39. John Sutton MG, Tajik AJ, McGoon DC. Atrial septal defect in patients ages 60 years or older: operative results and long-term postoperative follow-up. Circulation. 1981; 64: 402409.
40. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, van Domburg R, van Rijen EH, Utens EM, Bogers AJ, Simoons ML. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age: a prospective follow-up study of 2133 years. Eur Heart J. 2003; 24: 190197.
41. Kobayashi J, Yamamoto F, Nakano K, Sasako Y, Kitamura S, Kosakai Y. Maze procedure for atrial fibrillation associated with atrial septal defect. Circulation. 1998; 98 (suppl): II-399II-402.[Medline] [Order article via Infotrieve]
42. Varma C, Benson LN, Silversides C, Yip J, Warr MR, Webb G, Siu SC, McLaughlin PR. Outcomes and alternative techniques for device closure of the large secundum atrial septal defect. Catheter Cardiovasc Interv. 2004; 61: 131139.[CrossRef][Medline] [Order article via Infotrieve]
43. Fredriksen PM, Veldtman G, Hechter S, Therrien J, Chen A, Warsi MA, Freeman M, Liu P, Siu S, Thaulow E, Webb G. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol. 2001; 87: 310314.[CrossRef][Medline] [Order article via Infotrieve]
44. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005; 112: 828835.
45. Gatzoulis MA, Redington AN, Somerville J, Shore DF. Should atrial septal defects in adults be closed? Ann Thorac Surg. 1996; 61: 657659.
46. Helber U, Baumann R, Seboldt H, Reinhard U, Hoffmeister HM. Atrial septal defect in adults: cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure. J Am Coll Cardiol. 1997; 29: 13451350.[Abstract]
47. Veldtman GR, Razack V, Siu S, El-Hajj H, Walker F, Webb GD, Benson LN, McLaughlin PR. Right ventricular form and function after percutaneous atrial septal defect device closure. J Am Coll Cardiol. 2001; 37: 21082113.
48. Brochu MC, Baril JF, Dore A, Juneau M, De Guise P, Mercier LA. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation. 2002; 106: 18211826.
49. Giardini A, Moore P, Brook M, Stratton V, Tacy T. Effect of transcatheter atrial septal defect closure in children on left ventricular diastolic function. Am J Cardiol. 2005; 95: 12551257.[CrossRef][Medline] [Order article via Infotrieve]
50. Giardini A, Donti A, Formigari R, Specchia S, Prandstraller D, Bronzetti G, Bonvicini M, Picchio FM. Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adults. J Am Coll Cardiol. 2004; 43: 18861891.
51. Giardini A, Donti A, Specchia S, Coutsoumbas G, Formigari R, Prandstraller D, Bronzetti G, Bonvicini M, Picchio FM. Recovery kinetics of oxygen uptake is prolonged in adults with an atrial septal defect and improves after transcatheter closure. Am Heart J. 2004; 147: 910914.[CrossRef][Medline] [Order article via Infotrieve]
52. Kort HW, Balzer DT, Johnson MC. Resolution of right heart enlargement after closure of secundum atrial septal defect with transcatheter technique. J Am Coll Cardiol. 2001; 38: 15281532.
53. Schussler JM, Anwar A, Phillips SD, Roberts BJ, Vallabhan RC, Grayburn PA. Effect on right ventricular volume of percutaneous Amplatzer closure of atrial septal defect in adults. Am J Cardiol. 2005; 95: 993995.[CrossRef][Medline] [Order article via Infotrieve]
54. Salehian O, Horlick E, Schwerzmann M, Haberer K, McLaughlin P, Siu SC, Webb G, Therrien J. Improvements in cardiac form and function after transcatheter closure of secundum atrial septal defects. J Am Coll Cardiol. 2005; 45: 499504.
55. Walker RE, Moran AM, Gauvreau K, Colan SD. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol. 2004; 93: 13741377, A1376.
56. Attenhofer Jost CH, Oechslin E, Seifert B, Maly F, Fatio R, Turina J, Jenni R. Remodelling after surgical repair of atrial septal defects within the oval fossa. Cardiol Young. 2002; 12: 506512.[CrossRef][Medline] [Order article via Infotrieve]
57. Cherian G, Uthaman CB, Durairaj M, Sukumar IP, Krishnaswami S, Jairaj PS, John S, Krishnaswami H, Bhaktaviziam A. Pulmonary hypertension in isolated secundum atrial septal defect: high frequency in young patients. Am Heart J. 1983; 105: 952957.[CrossRef][Medline] [Order article via Infotrieve]
58. Khoury GH, Hawes CR. Atrial septal defect associated with pulmonary hypertension in children living at high altitude. J Pediatr. 1967; 70: 432435.[CrossRef][Medline] [Order article via Infotrieve]
59. Willerson JT, Baggett AE Jr, Thomas JW, Goldblatt A. Ventricular septal defect with altitude-dependent pulmonary hypertension. N Engl J Med. 1971; 285: 157158.[Medline] [Order article via Infotrieve]
60. Vogel M, Berger F, Kramer A, Alexi-Meshkishvili V, Lange PE. Incidence of secondary pulmonary hypertension in adults with atrial septal or sinus venosus defects. Heart. 1999; 82: 3033.
61. Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease: long-term follow-up and prediction of outcome after surgical correction. Circulation. 1987; 76: 10371042.
62. Frost AE, Quinones MA, Zoghbi WA, Noon GP. Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J Heart Lung Transplant. 2005; 24: 501503.[CrossRef][Medline] [Order article via Infotrieve]
63. Schwerzmann M, Zafar M, McLaughlin PR, Chamberlain DW, Webb G, Granton J. Atrial septal defect closure in a patient with "irreversible" pulmonary hypertensive arteriopathy. Int J Cardiol. 2006; 110: 104107.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
G. Yong, P. Khairy, P. De Guise, A. Dore, F. Marcotte, L.-A. Mercier, S. Noble, and R. Ibrahim Pulmonary Arterial Hypertension in Patients With Transcatheter Closure of Secundum Atrial Septal Defects: A Longitudinal Study Circ Cardiovasc Interv, October 1, 2009; 2(5): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
K DEBL, B DJAVIDANI, S BUCHNER, N HEINICKE, F POSCHENRIEDER, S FEUERBACH, G RIEGGER, and A LUCHNER Quantification of left-to-right shunting in adult congenital heart disease: phase-contrast cine MRI compared with invasive oximetry Br. J. Radiol., May 1, 2009; 82(977): 386 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Martucci and M. Landzberg Not Just Big Kids: Closing Atrial Septal Defects in Adults Older Than 60 Years Circ Cardiovasc Interv, April 1, 2009; 2(2): 83 - 84. [Full Text] [PDF] |
||||
![]() |
F. Haddad, P. Couture, C. Tousignant, and A. Y. Denault The Right Ventricle in Cardiac Surgery, a Perioperative Perspective: II. Pathophysiology, Clinical Importance, and Management Anesth. Analg., February 1, 2009; 108(2): 422 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schwerzmann, S. Windecker, and B. Meier Swiss Cheese-Like Atrial Septal Defect Circulation, June 17, 2008; 117(24): e490 - e492. [Full Text] [PDF] |
||||
![]() |
Y. Zhu, A. O. Gramolini, M. A. Walsh, Y.-Q. Zhou, C. Slorach, M. K. Friedberg, J. K. Takeuchi, H. Sun, R. M. Henkelman, P. H. Backx, et al. Tbx5-dependent pathway regulating diastolic function in congenital heart disease PNAS, April 8, 2008; 105(14): 5519 - 5524. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haddad, R. Doyle, D. J. Murphy, and S. A. Hunt Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure Circulation, April 1, 2008; 117(13): 1717 - 1731. [Full Text] [PDF] |
||||
![]() |
E. Bedard, D. F. Shore, and M. A. Gatzoulis Adult congenital heart disease: a 2008 overview Br. Med. Bull., March 1, 2008; 85(1): 151 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Sommer, Z. M. Hijazi, and J. F. Rhodes Jr Pathophysiology of Congenital Heart Disease in the Adult: Part I: Shunt Lesions Circulation, February 26, 2008; 117(8): 1090 - 1099. [Full Text] [PDF] |
||||
![]() |
J. Klcovansky, L. Sondergaard, M. Helvind, and H. O. Andersen Cardiac surgery in grown-up congenital heart patients. Will the surgical workload increase? Interactive CardioVascular and Thoracic Surgery, February 1, 2008; 7(1): 84 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Khairy and A. J. Marelli Clinical Use of Electrocardiography in Adults With Congenital Heart Disease Circulation, December 4, 2007; 116(23): 2734 - 2746. [Full Text] [PDF] |
||||
![]() |
C. L Bose and M. M Laughon Patent ductus arteriosus: lack of evidence for common treatments Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2007; 92(6): F498 - F502. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |